FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3186296039> ?p ?o ?g. }

• W3186296039 abstract "Background: Investigating drug utilization in large and unselected samples of children and adolescents is an important component of public health monitoring. Most existing studies in this field focused on any drug use (i.e., ≥1 prescription of a certain drug) although chronic drug use may be more relevant. This study aimed to provide a comprehensive overview of prevalence and types of prescription drugs used repeatedly in children and adolescents in Germany in 2016. Methods: We used the German Pharmacoepidemiological Research Database (GePaRD)—a claims database covering ∼20% of the German population. We included children and adolescents aged 0–17 years and assessed repeated use of prescription drugs (≥3 prescriptions in 2016) on two levels: therapeutic subgroups (ATC 2nd level) and chemical substances (ATC 5th level). Analyses were stratified by sex and age groups (&lt;2, 2–5, 6–12, and 13–17 years). Results: Overall, 2.5 million children and adolescents were included. In the age groups below 13 years, the prevalence rates of repeated use of prescription drugs (ATC 2nd level) were higher in boys than in girls (113–152 vs. 83–130 per 1,000 person-years), whereas in the age group 13–17 years, they were twice as high in girls than in boys (236 vs. 118 per 1,000 person-years). In boys and girls aged below six years, systemic antibiotics, topical ocular antibiotics, and drugs for constipation were among the most common drugs used repeatedly. For higher ages, methylphenidate, levothyroxine, and combined hormonal contraceptives, were among the most common drugs used repeatedly. Conclusions: Overall, about one in ten children in Germany repeatedly used prescription drugs. This proportion as well as the type of drugs used repeatedly markedly varied by sex and age. For certain drugs, our findings raise concerns regarding appropriateness of prescribing that should be addressed in future studies." @default.
• W3186296039 created "2021-08-02" @default.
• W3186296039 creator A5009305200 @default.
• W3186296039 creator A5029303678 @default.
• W3186296039 creator A5043547332 @default.
• W3186296039 creator A5081350399 @default.
• W3186296039 creator A5087654536 @default.
• W3186296039 date "2021-07-15" @default.
• W3186296039 modified "2023-09-27" @default.
• W3186296039 title "Repeated Use of Prescription Drugs in Pediatrics: Comprehensive Overview Based on German Claims Data" @default.
• W3186296039 cites W1966920959 @default.
• W3186296039 cites W2047119531 @default.
• W3186296039 cites W2063911109 @default.
• W3186296039 cites W2067620066 @default.
• W3186296039 cites W2113105996 @default.
• W3186296039 cites W2141248662 @default.
• W3186296039 cites W2142707382 @default.
• W3186296039 cites W2147291501 @default.
• W3186296039 cites W2347049117 @default.
• W3186296039 cites W2507115133 @default.
• W3186296039 cites W2543821519 @default.
• W3186296039 cites W2608178729 @default.
• W3186296039 cites W2790432733 @default.
• W3186296039 cites W2793743329 @default.
• W3186296039 cites W2797285236 @default.
• W3186296039 cites W2923338708 @default.
• W3186296039 cites W2943169699 @default.
• W3186296039 cites W2966494958 @default.
• W3186296039 cites W3001881339 @default.
• W3186296039 cites W3033220769 @default.
• W3186296039 cites W3125149538 @default.
• W3186296039 cites W44565221 @default.
• W3186296039 doi "https://doi.org/10.3389/fphar.2021.706682" @default.
• W3186296039 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8319624" @default.
• W3186296039 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34335267" @default.
• W3186296039 hasPublicationYear "2021" @default.
• W3186296039 type Work @default.
• W3186296039 sameAs 3186296039 @default.
• W3186296039 citedByCount "1" @default.
• W3186296039 countsByYear W31862960392022 @default.
• W3186296039 crossrefType "journal-article" @default.
• W3186296039 hasAuthorship W3186296039A5009305200 @default.
• W3186296039 hasAuthorship W3186296039A5029303678 @default.
• W3186296039 hasAuthorship W3186296039A5043547332 @default.
• W3186296039 hasAuthorship W3186296039A5081350399 @default.
• W3186296039 hasAuthorship W3186296039A5087654536 @default.
• W3186296039 hasBestOaLocation W31862960391 @default.
• W3186296039 hasConcept C118552586 @default.
• W3186296039 hasConcept C138816342 @default.
• W3186296039 hasConcept C154775046 @default.
• W3186296039 hasConcept C159110408 @default.
• W3186296039 hasConcept C166957645 @default.
• W3186296039 hasConcept C187212893 @default.
• W3186296039 hasConcept C23276603 @default.
• W3186296039 hasConcept C2426938 @default.
• W3186296039 hasConcept C2777112843 @default.
• W3186296039 hasConcept C2780035454 @default.
• W3186296039 hasConcept C2780783007 @default.
• W3186296039 hasConcept C2908647359 @default.
• W3186296039 hasConcept C512399662 @default.
• W3186296039 hasConcept C71924100 @default.
• W3186296039 hasConcept C95457728 @default.
• W3186296039 hasConcept C98274493 @default.
• W3186296039 hasConcept C99454951 @default.
• W3186296039 hasConceptScore W3186296039C118552586 @default.
• W3186296039 hasConceptScore W3186296039C138816342 @default.
• W3186296039 hasConceptScore W3186296039C154775046 @default.
• W3186296039 hasConceptScore W3186296039C159110408 @default.
• W3186296039 hasConceptScore W3186296039C166957645 @default.
• W3186296039 hasConceptScore W3186296039C187212893 @default.
• W3186296039 hasConceptScore W3186296039C23276603 @default.
• W3186296039 hasConceptScore W3186296039C2426938 @default.
• W3186296039 hasConceptScore W3186296039C2777112843 @default.
• W3186296039 hasConceptScore W3186296039C2780035454 @default.
• W3186296039 hasConceptScore W3186296039C2780783007 @default.
• W3186296039 hasConceptScore W3186296039C2908647359 @default.
• W3186296039 hasConceptScore W3186296039C512399662 @default.
• W3186296039 hasConceptScore W3186296039C71924100 @default.
• W3186296039 hasConceptScore W3186296039C95457728 @default.
• W3186296039 hasConceptScore W3186296039C98274493 @default.
• W3186296039 hasConceptScore W3186296039C99454951 @default.
• W3186296039 hasFunder F4320328691 @default.
• W3186296039 hasLocation W31862960391 @default.
• W3186296039 hasLocation W31862960392 @default.
• W3186296039 hasLocation W31862960393 @default.
• W3186296039 hasLocation W31862960394 @default.
• W3186296039 hasLocation W31862960395 @default.
• W3186296039 hasLocation W31862960396 @default.
• W3186296039 hasOpenAccess W3186296039 @default.
• W3186296039 hasPrimaryLocation W31862960391 @default.
• W3186296039 hasRelatedWork W1968509370 @default.
• W3186296039 hasRelatedWork W1968535865 @default.
• W3186296039 hasRelatedWork W1981858407 @default.
• W3186296039 hasRelatedWork W2071720887 @default.
• W3186296039 hasRelatedWork W2106798084 @default.
• W3186296039 hasRelatedWork W2134973209 @default.
• W3186296039 hasRelatedWork W2429641602 @default.
• W3186296039 hasRelatedWork W2511632883 @default.
• W3186296039 hasRelatedWork W2965202281 @default.
• W3186296039 hasRelatedWork W3186296039 @default.

• next